HGSI Related Analyst Ratings

Nov 30, 2009 09:33 AM Citigroup Lifts Price Target on Human Genome Sciences (HGSI) to $38

Nov 3, 2009 11:33 AM JPMorgan Boosts Target on Human Genome (HGSI) to $35

Nov 3, 2009 10:28 AM Goldman Sachs Lifts Tgt on Human Genome Sciences (HGSI) to $30, Sees As Acquisition Candidate

Nov 2, 2009 11:39 AM Barclays & Lazard Capital Upgrade Human Genome Sciences (HGSI)

Nov 2, 2009 11:05 AM Human Genome (HGSI) Second Successful Trial Sets Stage For Benlysta Approval

Nov 2, 2009 07:49 AM Leerink Swann Lifts Price Target On Human Genome Sciences (HGSI) to $40

Oct 29, 2009 09:09 AM Human Genome (HGSI) Jumps as JPMorgan Upgrades to Overweight

Oct 15, 2009 06:56 AM Goldman Sachs Resumes Human Genome Sciences (HGSI) at Buy, Sees As Potential Takeover Target

Oct 5, 2009 11:32 AM Leerink Swann Makes Comments on Human Genome Sciences (HGSI); Sees Value in Prime Candidates

Sep 14, 2009 03:19 PM Human Genome Sciences (HGSI) Climbs Higher On Takeover Speculation

Sep 14, 2009 09:47 AM Piper Jaffray Reiterates an 'Overweight' Rating on Human Genome Sciences (HGSI); Optimistic About BLISS-76 Data in November

Aug 11, 2009 08:18 AM Leerink Swann Raises Price Target On Human Genome (HGSI) To 'Street High' $30/Share

Aug 4, 2009 07:44 AM Human Genome Sciences (HGSI): Upgraded to Buy at ThinkEquity; target raised to $26 (new Street high)

Aug 4, 2009 07:31 AM ThinkEquity Upgrades Human Genome Sciences (HGSI) to Buy

Jul 21, 2009 12:59 PM Analysts Still Jumping on Human Genome Sciences (HGSI) Bandwagon: 3 Upgrades Today

Jul 21, 2009 07:46 AM Bernstein Upgrades Human Genome Sciences (HGSI) to Outperform

Jul 20, 2009 04:19 PM After a Nearly 280% Surge In Human Genome Sciences (HGSI) Is There More Upside?

Jul 20, 2009 12:09 PM Piper Jaffray Jumps On Human Genome Sciences (HGSI) Bandwagon, Upgrades to Buy

Jul 20, 2009 10:59 AM Citi & Lazard Capital Jump on Bandwagon - Upgrade Human Genome Sciences (HGSI)

Jul 16, 2009 01:31 PM Human Genome Sciences (HGSI) Surges Higher Ahead of Benlysta Data

Jul 13, 2009 07:37 AM UBS Downgrades Human Genome Sciences (HGSI) to Neutral

Jun 12, 2009 08:03 AM Lazard Downgrades Human Genome Sciences (HGSI) to Sell

Jun 5, 2009 08:47 AM ThinkEquity Downgrades Human Genome Sciences (HGSI) to Source of Funds

Mar 9, 2009 03:00 PM Baird Downgrades Human Genome (HGSI) to Neutral; Moving to Sidelines

Mar 9, 2009 02:43 PM JMP Securities Downgrades Human Genome Sciences (HGSI) to Market Perform

Mar 9, 2009 10:34 AM Piper Jaffray Downgrades Human Genome Sciences (HGSI) to Neutral; Albuferon SVR Rate Inferior to Pegasys

Dec 10, 2008 10:34 AM Stanford Group Upgrades Human Genome (HGSI) to Buy

Nov 11, 2008 09:03 AM Susquehanna Downgrades Human Genome Sciences (HGSI) to Neutral

Apr 17, 2008 08:07 AM Citi Downgrades Human Genome Sciences (HGSI) to Hold

Feb 26, 2008 10:14 AM Baird Would Be Buyers of Human Genome Sciences Into $10 Range (HGSI)

Jan 24, 2008 09:30 AM Baird Upgrades Human Genome Sciences (HGSI) to Outperform

Jan 24, 2008 09:17 AM Piper Jaffray Upgrades Human Genome Sciences (HGSI) to Buy

Jan 24, 2008 07:33 AM Bear Stearns Upgrades Human Genome (HGSI) to Outperform

Jan 23, 2008 10:49 AM Merrill Lynch downgrades Human Genome Sciences (HGSI) to Neutral

Sep 18, 2007 09:49 AM Bernstein Starts Human Genome (HGSI) at Outperform

Jun 26, 2007 08:02 AM Lehman Brothers downgrades Human Genome Sciences (HGSI) to Equal Weight

Apr 23, 2007 11:21 AM Rodman & Renshaw Comments on the "Aftershock" of MEDI/AZN Deal

Jan 31, 2007 08:53 AM Stifel Nicolaus Starts Human Genome Sciences (HGSI) at Buy

Jan 4, 2007 09:38 AM AG Edwards reinitiates Human Genome Sciences (HGSI) at Buy

Oct 12, 2006 10:28 AM Lazard Capital Initiates Coverage on Human Genome Sciences (HGSI) with a Sell

Oct 11, 2006 09:31 AM Thomas Weisel Starts Human Genome Sciences (HGSI) at Outperform

Oct 3, 2006 07:43 AM Human Genome Science (HGSI) October implied volatility at 64, November at 54 into 10/4 analyst Day

Jun 23, 2006 07:51 AM Deutsche Bank Starts Human Genome Sciences (HGSI) at Buy

Jun 8, 2006 12:19 AM Citigroup Addresses Concerns on Human Genome Sciences (HGSI)

May 30, 2006 02:45 PM UBS upgrades Human Genome Sciences Inc. (HGSI) to Buy - Bloomberg

May 23, 2006 03:37 PM Jim Cramer Comments on AAPL, PCU, AA & HGSI

May 1, 2006 09:29 AM ThinkEquity upgrades Human Genome (HGSI) to Buy

Apr 21, 2006 08:12 AM ThinkEquity Starts Human Genome (HGSI) at Accmulate

Apr 18, 2006 07:25 AM Bear Stearns Starts Human Genome Sciences (HGSI) at Peer Perform

Apr 5, 2006 07:48 AM Thomas Weisel Starts Human Genome Sciences (HGSI) at Peer Perform